Ryan Maynard - 31 May 2022 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Director
Signature
/s/ Ryan Maynard
Issuer symbol
IOVA
Transactions as of
31 May 2022
Net transactions value
+$50,588
Form type
4
Filing time
02 Jun 2022, 20:02:55 UTC
Previous filing
01 Jul 2021
Next filing
14 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOVA Common Stock Purchase $50,588 +7,500 $6.74 7,500 31 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.